Neurotech News for Public Markets Updated Every 15 Minutes. Brain Waves: The field of neurotechnology, the focus of this blog, encompasses advances in brain science (neurons), information technology (bits) and bioengineering (genes). Up for discussion and analysis: the political, economic, ethical, and social forces that will shape the future of what will be one of the most important and fascinating stories of the coming decades.

About this author

Zack Lynch is author of The Neuro Revolution: How Brain Science Is Changing Our World (St. Martin's Press, July 2009).
He is the founder and executive director of the Neurotechnology Industry Organization (NIO) and co-founder of NeuroInsights. He serves on the advisory boards of the McGovern Institute for Brain Research at MIT, the Center for Neuroeconomic Studies, Science Progress, and SocialText, a social software company. Please send newsworthy items or feedback - to Zack Lynch.
Follow me on Twitter at @neurorev

Receive by email

GUEST AUTHOR ARCHIVES

In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

« Neurotech Index - A Public Market Benchmark for the Neurotechnology Industry | Main | Best Japanese Neuroscience Blog »

May 24, 2005

Neurotech News for Public Markets Updated Every 15 Minutes

Posted by Zack Lynch

To compliment the development of NeuroInsights' Neurotech Index we have also developed a neurotech market news feed that brings up-to-the minute market news on public neurotech companies. Here are a sampling of the latest neurotech news items at of 11:30 am EST for May 24th: (updated market news can be found by following the above link)

• Eyetech Falls Despite Brazilian Approval (AP) May 24, 2005 06:21:33 am. Eyetech Pharmaceuticals Inc. said Tuesday that it received approval for its age-related macular degeneration treatment Macugen in Brazil, but its shares plummeted following positive data released on a competing Genentech Inc. treatment.
• Genentech's Lucentis Could Eclipse Macugen (at Forbes.com) May 24, 2005 05:54:34 am
• Prana Biotechnology to Present at the Needham & Company Fourth Annual Biotechnology Conference (PR Newswire) May 24, 2005 05:30:00 am
• DOV Pharmaceutical, Inc. to Present at The Fourth Annual Needham Biotechnology Conference (PR Newswire) posted on May 24, 2005 05:00:00 am
• New River Pharma upgraded by Wells Fargo Sec (Briefing.com) May 24, 2005 04:40:32 am
• Amarin Corporation Plc Announces First Quarter 2005 Earnings Conference Call (PR Newswire) posted on May 24, 2005 04:35:00 am. Amarin Corporation lc today announced that it will be discussing its first quarter 2005 results in a conference call at 9.00 am on Thursday, May 26th, 2005. Rick Stewart, chief executive officer, and Alan Cooke, chief financial officer, can be heard by dialling +1--968-7995 in the U.S. or +1--679-8403 elsewhere.
• Bio-logic Reports Fourth Quarter and Fiscal 2005 Results (Business Wire)
posted on May 24, 2005 04:00:00 am. Bio-logic Systems Corp., a designer and marketer of computerized medical electro-diagnostic equipment and disposables, today reported financial results for the fourth quarter and fiscal year ended February 28, 2005.